Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Stroke. 2011 Oct 13;42(12):3347–3351. doi: 10.1161/STROKEAHA.111.620773

Table 1.

Baseline characteristics of Cardiovascular Health Study participants without diabetes or history of stroke (n=3,442)*

← More insulin resistant Less insulin resistant →
Quartiles of Gutt insulin sensitivity index (mg·L2/mmol·mU·min)
Characteristic, mean (SD) or % 25.8 to 47
(n = 843)
>47 to 60
(n = 874)
>60 to 77
(n = 862)
>77 to 218.2
(n = 863)
Age, y 72.9 (5.7) 72.8 (5.6) 72.7 (5.6) 72.1 (5.3)
Male sex, % 44.1% 38.9% 38.5% 47.3%
Black race, % 4.0% 3.2% 5.1% 3.9%
Fasting glucose, mmol/L 5.8 (0.5) 5.6 (0.5) 5.4 (0.4) 5.3 (0.4)
2-hr glucose, mmol/L 9.2 (1.0) 7.7 (1.0) 6.5 (0.9) 5.1 (0.9)
Fasting insulin, pmol/L 121.5 (58.3) 94.5 (42.4) 83.3 (43.8) 72.9 (28.5)
2-hr insulin, pmol/L 966.7 (486.2) 569.5 (224.3) 402.8 (164.6) 222.9 (93.1)
Body weight, kg 75.3 (14.2) 71.4 (13.8) 68.5 (13.5) 67.7 (12.9)
Waist circumference, cm 97.4 (12.0) 93.4 (12.3) 90.3 (11.8) 88.2 (11.9)
Physical activity, kcal/wk 1,788 (2,141) 1,921 (2,118) 1,847 (2,051) 1,998 (2,008)
eGFR <60 mL/min/1.73 m2, % 43.7% 42.6% 36.7% 39.6%
Coronary heart disease, % 20.3% 17.3% 14.0% 16.1%
Congestive heart failure, % 5.0% 3.3% 2.3% 1.6%
Atrial fibrillation, % 3.0% 3.1% 1.6% 1.9%
Peripheral arterial disease, % 2.1% 2.5% 1.6% 2.1%
Systolic blood pressure, mmHg 137.2 (21.1) 136.2 (20.6) 133.8 (20.7) 130.0 (21.9)
Antihypertensive medication use, % 52.3% 38.3% 35.4% 32.1%
Triglyceride, mmol/L 1.7 (0.7) 1.5 (0.6) 1.4 (0.6) 1.3 (0.5)
HDL cholesterol, mmol/L 1.3 (0.3) 1.4 (0.4) 1.5 (0.4) 1.5 (0.4)
LDL cholesterol, mmol/L 3.4 (0.9) 3.5 (0.9) 3.4 (0.9) 3.3 (0.9)
*

Abbreviations: SD, standard deviation; eGFR, estimated glomerular filtration rate; HDL, high density lipoprotein; LDL, low density lipoprotein.

Conversions: glucose, mg/dL = (mmol/L)/0.0555; insulin, μU/mL = (pmol/L)/6.945; triglyceride, mg/dL = (mmol/L)/0.0113; HDL and LDL cholesterol, mg/dL = (mmol/L)/0.0259.